Read More
Adv
OXIS Reverse Stock Split: A Case Study

OXIS Reverse Stock Split: A Case Study

Oxis Biotech, a subsidiary of Oxis International (OTCQB: OXIS), recently filed a notification to shareholders and the SEC that the company would be entering into a reverse split of not less than 1-50 shares and not more than 1-250 shares.

Read All
Top